ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma - Vitolo, U; Witzig, T E; Gascoyne, R D (Hematological Oncology, 2019)
. doi:10.1002/hon.5_2629